TABLE 6

Enzyme kinetics for cytochrome P450 CYP3A catalyzed reactions in recombinant human CYP3A4 and CYP3A5a

CYP3A4CYP3A5CLint Ratio
KM ± S.E.Vmax ± S.E.CLintKM ± S.E.Vmax ± S.E.CLint(3A5/3A4)
Alprazolam
 1′-Hydroxylation55 ± 94.1 ± 0.20.07440 ± 86.1 ± 0.20.152.0
 4-Hydroxylation130 ± 1754 ± 30.41100 ± 1024 ± 70.240.59
Midazolam
 1′-Hydroxylation1.8 ± 0.43.9 ± 0.32.20.84 ± 0.1723 ± 12812
 4-Hydroxylation7.8 ± 0.92.9 ± 0.20.387.5 ± 1.05.0 ± 0.20.671.8
Triazolam
 1′-Hydroxylation9.4 ± 1.024 ± 12.61.7 ± 0.917 ± 0103.8
 4-Hydroxylation40 ± 641 ± 11.052 ± 328 ± 00.520.52
Testosterone
 6β-hydroxylation14 ± 260 ± 24.457 ± 5140 ± 52.30.52
Atazanavir
 Phenyl p-hydroxylation2.5 ± 0.60.094 ± 0.0060.0383.9 ± 0.80.75 ± 0.040.195.0
t-Butyl hydroxylation2.5 ± 0.40.38 ± 0.100.155.3 ± 1.21.9 ± 0.10.362.4
  • CLint, intrinsic clearance.

  • a Units: KM: µM; Vmax: nmol/min/nmol; CYP CLint: ml/min/nmol;